Skip to main content

Table 1 Demographic characteristics

From: Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome

 

Valvar (n = 20)

P* value

CAD/MS group

Control (n = 17)

Simvastatin (n = 20)

Pioglitazone (n = 18)

Pioglitazone + Simvastatin (n = 18)

P** value

Age (yrs)

52.3 ± 8.0

<0.001

64.3 ± 6.06

60.1 ± 6.38

57.6 ± 5.89

60.1 ± 7.08

0.024

Male (%)

6(30)

0.005

12(70.6)

16(80)

10 (55.6)

10 (55.6)

0.314

Waist circumference (cm)

78.4 ± 11.9

<0.001

103.6 ± 6.43

103.2 ± 8.62

103.7 ± 8.09

105.2 ± 9.06

0.883

Systolic BP (mmHg)

113 ± 10.3

<0.001

145 ± 17.1

134 ± 15.1

162 ± 20.3

145 ± 13.8

<0.001

Diastolic BP (mmHg)

72 ± 11.5

0.006

87 ± 11.8

78 ± 10.3

85 ± 12

73 ± 11.2

0.001

Baseline Weight (Kg)

58.9 ± 12.4

<0.001

85.8 ± 13.7

76.7 ± 10.8

80.6 ± 13.7

83.9 ± 10.2

0.122

Final Weight (Kg)

57.2 ± 11.9

<0.001

82.5 ± 12.9

74.6 ± 10.5

81.4 ± 14.6

83.3 ± 9.3

0.102

  1. Values are means ± SD or n(%). CAD = coronary artery disease; BP = blood pressure. P* value = Comparison between non-CAD group and CAD/MS group. P** value = Comparison between CAD/MS groups.